NSN Co. Ltd (031860) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.143x

Based on the latest financial reports, NSN Co. Ltd (031860) has a cash flow conversion efficiency ratio of -0.143x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.89 Billion ≈ $-1.96 Million USD) by net assets (₩20.26 Billion ≈ $13.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 031860 net asset quality score to measure how much of total assets are equity-financed.

NSN Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how NSN Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 031860 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

NSN Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NSN Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Global Surfaces Limited
NSE:GSLSU
0.033x
Inter-M Corporation
KQ:017250
-0.056x
Overactive Media Corp
V:OAM
0.033x
M Cash Integrasi Tbk PT
JK:MCAS
-0.044x
Concord Medical Services Holdings
NYSE:CCM
0.009x
Leaders Cosmetics Co. Ltd
KQ:016100
0.004x
KB SPAC 6
KQ:208640
-0.119x
Nukkleus Inc
NASDAQ:NUKK
0.033x

Annual Cash Flow Conversion Efficiency for NSN Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of NSN Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see NSN Co. Ltd (031860) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩20.26 Billion
≈ $13.73 Million
₩-8.86 Billion
≈ $-6.01 Million
-0.437x -274.65%
2024-12-31 ₩48.12 Billion
≈ $32.61 Million
₩-5.62 Billion
≈ $-3.81 Million
-0.117x +12.82%
2023-12-31 ₩59.75 Billion
≈ $40.49 Million
₩-8.00 Billion
≈ $-5.42 Million
-0.134x +29.67%
2022-12-31 ₩59.58 Billion
≈ $40.38 Million
₩-11.35 Billion
≈ $-7.69 Million
-0.190x +40.54%
2021-12-31 ₩38.49 Billion
≈ $26.08 Million
₩-12.33 Billion
≈ $-8.35 Million
-0.320x -266.26%
2020-12-31 ₩51.00 Billion
≈ $34.56 Million
₩-4.46 Billion
≈ $-3.02 Million
-0.087x +54.68%
2019-12-31 ₩22.70 Billion
≈ $15.38 Million
₩-4.38 Billion
≈ $-2.97 Million
-0.193x +32.29%
2018-12-31 ₩18.37 Billion
≈ $12.45 Million
₩-5.23 Billion
≈ $-3.55 Million
-0.285x +29.34%
2017-12-31 ₩20.42 Billion
≈ $13.84 Million
₩-8.24 Billion
≈ $-5.58 Million
-0.403x -46.84%
2016-12-31 ₩22.41 Billion
≈ $15.18 Million
₩-6.15 Billion
≈ $-4.17 Million
-0.275x +1.90%
2015-12-31 ₩23.86 Billion
≈ $16.17 Million
₩-6.68 Billion
≈ $-4.53 Million
-0.280x -229.13%
2014-12-31 ₩29.52 Billion
≈ $20.00 Million
₩-2.51 Billion
≈ $-1.70 Million
-0.085x --

About NSN Co. Ltd

KQ:031860 Korea Diagnostics & Research
Market Cap
$12.68 Million
₩18.71 Billion KRW
Market Cap Rank
#26420 Global
#1986 in Korea
Share Price
₩693.00
Change (1 day)
+17.26%
52-Week Range
₩265.00 - ₩998.00
All Time High
₩146500.00
About

DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution… Read more